{
    "title": "Tick-Borne Disease Research Accountability and Transparency Act of 2014",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Tick-Borne Disease Research \nAccountability and Transparency Act of 2014''.\n\nSEC. 2. LYME DISEASE AND OTHER TICK-BORNE DISEASES.\n\n    Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) \nis amended by adding at the end the following new part:\n\n          ``PART W--LYME DISEASE AND OTHER TICK-BORNE DISEASES\n\n``SEC. 399OO. RESEARCH.\n\n    ``(a) In General.--The Secretary shall conduct or support \nepidemiological, basic, translational, and clinical research regarding \nLyme disease and other tick-borne diseases.\n    ``(b) Biennial Reports.--The Secretary shall ensure that each \nbiennial report under section 403 includes information on actions \nundertaken by the National Institutes of Health to carry out subsection \n(a) with respect to Lyme disease and other tick-borne diseases, \nincluding an assessment of the progress made in improving the outcomes \nof Lyme disease and such other tick-borne diseases.\n\n``SEC. 399OO-1. WORKING GROUP.\n\n    ``(a) Establishment.--The Secretary shall establish a permanent \nworking group, to be known as the Interagency Lyme and Tick-Borne \nDisease Working Group (in this section and section 399OO-2 referred to \nas the `Working Group'), to review all efforts within the Department of \nHealth and Human Services concerning Lyme disease and other tick-borne \ndiseases to ensure interagency coordination, minimize overlap, and \nexamine research priorities.\n    ``(b) Responsibilities.--The Working Group shall--\n            ``(1) not later than 24 months after the date of enactment \n        of this part, and every 24 months thereafter, develop or update \n        a summary of--\n                    ``(A) ongoing Lyme disease and other tick-borne \n                disease research related to causes, prevention, \n                treatment, surveillance, diagnosis, diagnostics, \n                duration of illness, intervention, and access to \n                services and supports for individuals with Lyme disease \n                or other tick-borne diseases;\n                    ``(B) advances made pursuant to such research;\n                    ``(C) the engagement of the Department of Health \n                and Human Services with persons that participate at the \n                public meetings required by paragraph (5); and\n                    ``(D) the comments received by the Working Group at \n                such public meetings and the Secretary's response to \n                such comments;\n            ``(2) ensure that a broad spectrum of scientific viewpoints \n        is represented in each such summary;\n            ``(3) monitor Federal activities with respect to Lyme \n        disease and other tick-borne diseases;\n            ``(4) make recommendations to the Secretary regarding any \n        appropriate changes to such activities; and\n            ``(5) ensure public input by holding annual public meetings \n        that address scientific advances, research questions, \n        surveillance activities, and emerging strains in species of \n        pathogenic organisms.\n    ``(c) Membership.--\n            ``(1) In general.--The Working Group shall be composed of a \n        total of 14 members as follows:\n                    ``(A) Federal members.--Seven Federal members, \n                consisting of one or more representatives of each of--\n                            ``(i) the Office of the Assistant Secretary \n                        for Health;\n                            ``(ii) the Food and Drug Administration;\n                            ``(iii) the Centers for Disease Control and \n                        Prevention;\n                            ``(iv) the National Institutes of Health; \n                        and\n                            ``(v) such other agencies and offices of \n                        the Department of Health and Human Services as \n                        the Secretary determines appropriate.\n                    ``(B) Non-federal public members.--Seven non-\n                Federal public members, consisting of representatives \n                of the following categories:\n                            ``(i) Physicians and other medical \n                        providers with experience in diagnosing and \n                        treating Lyme disease and other tick-borne \n                        diseases.\n                            ``(ii) Scientists or researchers with \n                        expertise.\n                            ``(iii) Patients and their family members.\n                            ``(iv) Nonprofit organizations that \n                        advocate for patients with respect to Lyme \n                        disease and other tick-borne diseases.\n                            ``(v) Other individuals whose expertise is \n                        determined by the Secretary to be beneficial to \n                        the functioning of the Working Group.\n            ``(2) Appointment.--The members of the Working Group shall \n        be appointed by the Secretary, except that of the non-Federal \n        public members under paragraph (1)(B)--\n                    ``(A) one shall be appointed by the Speaker of the \n                House of Representatives; and\n                    ``(B) one shall be appointed by the Majority Leader \n                of the Senate.\n            ``(3) Diversity of scientific perspectives.--In making \n        appointments under paragraph (2), the Secretary, the Speaker of \n        the House of Representatives, and the Majority Leader of the \n        Senate shall ensure that the non-Federal public members of the \n        Working Group represent a diversity of scientific perspectives.\n            ``(4) Terms.--The non-Federal public members of the Working \n        Group shall each be appointed to serve a 4-year term and may be \n        reappointed at the end of such term.\n    ``(d) Meetings.--The Working Group shall meet as often as \nnecessary, as determined by the Secretary, but not less than twice each \nyear.\n    ``(e) Applicability of FACA.--The Working Group shall be treated as \nan advisory committee subject to the Federal Advisory Committee Act.\n    ``(f) Reporting.--Not later than 24 months after the date of \nenactment of this part, and every 24 months thereafter, the Working \nGroup--\n            ``(1) shall submit a report on its activities, including an \n        up-to-date summary under subsection (b)(1) and any \n        recommendations under subsection (b)(4), to the Secretary, the \n        Committee on Energy and Commerce of the House of \n        Representatives, and the Committee on Health, Education, Labor \n        and Pensions of the Senate;\n            ``(2) shall make each such report publicly available on the \n        website of the Department of Health and Human Services; and\n            ``(3) shall allow any member of the Working Group to \n        include in any such report minority views.\n\n``SEC. 399OO-2. STRATEGIC PLAN.\n\n    ``Not later than 3 years after the date of enactment of this \nsection, and every 5 years thereafter, the Secretary shall submit to \nthe Congress a strategic plan, informed by the most recent summary \nunder section 399OO-1(b)(1), for the conduct and support of Lyme \ndisease and tick-borne disease research, including--\n            ``(1) proposed budgetary requirements;\n            ``(2) a plan for improving outcomes of Lyme disease and \n        other tick-borne diseases, including progress related to \n        chronic or persistent symptoms and chronic or persistent \n        infection and co-infections;\n            ``(3) a plan for improving diagnosis, treatment, and \n        prevention;\n            ``(4) appropriate benchmarks to measure progress on \n        achieving the improvements described in paragraphs (2) and (3); \n        and\n            ``(5) a plan to disseminate each summary under section \n        399OO-1(b)(1) and other relevant information developed by the \n        Working Group to the public, including health care providers, \n        public health departments, and other relevant medical \n        groups.''.\n\nSEC. 3. NO ADDITIONAL AUTHORIZATION OF APPROPRIATIONS.\n\n    No additional funds are authorized to be appropriated to carry out \nthis Act and the amendment made by this Act, and this Act and such \namendment shall be\n\n\n              \n\n carried out using amounts otherwise available for such purpose.\n\n            Passed the House of Representatives September 9, 2014.\n\n            Attest:\n\n                                                 KAREN L. HAAS,\n\n                                                                 Clerk."
}